University/Organization: Independent Biotech Consultant
Rajeev Soni did his Ph.D. in Molecular Biology and Biotechnology from the University of Cambridge, U.K. and has 22 years of experience including industry and academia both nationally and internationally. He has been accredited with the discovery of G1 cyclins in plants during his Ph.D., a discovery that changed the whole course of plant growth and development field. Rajeev’s research has several patents to his credit including the patents on the development of a synthetic nuclease for bioterrorism applications while being at the Naval Research Lab in the USA. He has served as Associate Director, Biotechnology at Ranbaxy, were he was involved in drug discovery in the field of infectious and metabolic diseases.
He also had a stint at entrepreneurship where he served as President and COO of PREMAS Biotech, a CRAMS organization for 6 years. Rajeev then joined as an Associate VP in Biocon where he was responsible for the Molecular biology aspects of various projects, in particular being Insulin Glargine. His last assignment was as the Head of Protein Engineering at Novozymes, where he researched on the engineering and application of enzymes for various industrial applications. His specialization includes drug discovery research in the field of cancer and infectious diseases, industrial biotechnology with a focus on enzyme engineering for various applications, development of protein expression systems in various organisms, fund raising, strategic planning and business development.
His research interests are drug discovery research in the field of cancer and infectious diseases, industrial biotechnology with a focus on enzyme engineering for various applications, development of protein expression systems in various organisms.
Scientia Ricerca is licensed and content of this site is available under a Creative Commons Attribution 4.0 International License.